Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1495

1.

Heterogeneity in the clinical presentation, diagnosis, and treatment initiation of p16-positive oropharyngeal cancer.

Raman A, Sen N, Ritz E, Fidler MJ, Revenaugh P, Stenson K, Al-Khudari S.

Am J Otolaryngol. 2019 Sep - Oct;40(5):626-630. doi: 10.1016/j.amjoto.2019.05.004. Epub 2019 May 14.

PMID:
31174931
2.

Interplay between Phonons and Anisotropic Elasticity Drives Negative Thermal Expansion in PbTiO_{3}.

Ritz ET, Benedek NA.

Phys Rev Lett. 2018 Dec 21;121(25):255901. doi: 10.1103/PhysRevLett.121.255901.

PMID:
30608816
3.

Different Relevance of Peripheral, Central or Nighttime Blood Pressure Measurements in the Prediction of Chronic Kidney Disease Progression in Patients with Mild or No-Proteinuria.

Kuczera P, Kwiecień K, Adamczak M, Bączkowska T, Gozdowska J, Madziarska K, Augustyniak-Bartosik H, Klinger M, Durlik M, Ritz E, Wiecek A.

Kidney Blood Press Res. 2018;43(3):735-743. doi: 10.1159/000489749. Epub 2018 May 10.

4.

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Shimizu M, Kikuchi M, Shobu Y.

Clin Exp Nephrol. 2018 Apr;22(2):299-308. doi: 10.1007/s10157-017-1447-0. Epub 2017 Jul 24.

5.

Erratum: Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.

Seckinger J, Dschietzig W, Leimenstoll G, Rob PM, Kuhlmann MK, Pommer W, Fraass U, Ritz E, Schwenger V.

Clin Kidney J. 2017 Feb;10(1):141-143. doi: 10.1093/ckj/sfw141. Epub 2017 Jan 25.

6.

Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.

Seckinger J, Dschietzig W, Leimenstoll G, Rob PM, Kuhlmann MK, Pommer W, Fraass U, Ritz E, Schwenger V.

Clin Kidney J. 2016 Dec;9(6):839-848. Epub 2016 Sep 26. Erratum in: Clin Kidney J. 2017 Feb;10 (1):141-143.

7.

Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.

Kollerits B, Drechsler C, Krane V, Lamina C, März W, Dieplinger H, Ritz E, Wanner C, Kronenberg F; German Diabetes and Dialysis Study Investigators.

Nephrol Dial Transplant. 2016 Nov;31(11):1901-1908. Epub 2016 Jan 10.

PMID:
26754832
8.

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Shimizu M, Shobu Y, Kikuchi M.

BMC Nephrol. 2016 Sep 30;17(1):141.

9.

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.

Tomaschitz A, Verheyen N, Meinitzer A, Pieske B, Belyavskiy E, Brussee H, Haas J, März W, Pieske-Kraigher E, Verheyen S, Ofner-Ziegenfuss L, Hartaigh BÓ, Schwetz V, Aberer F, Grübler M, Lang F, Alesutan I, Voelkl J, Gaksch M, Horina JH, Dimai HP, Rus-Machan J, Stiegler C, Ritz E, Fahrleitner-Pammer A, Pilz S.

J Hypertens. 2016 Jul;34(7):1347-56. doi: 10.1097/HJH.0000000000000927.

PMID:
27065001
10.
11.

The double challenge of resistant hypertension and chronic kidney disease.

Rossignol P, Massy ZA, Azizi M, Bakris G, Ritz E, Covic A, Goldsmith D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Ortiz A, Vanholder R, Wiecek A, Zoccali C, London GM, Stengel B, Fouque D; ERA-EDTA EURECA-m working group; Red de Investigación Renal (REDINREN) network; Cardiovascular and Renal Clinical Trialists (F-CRIN INI-CRCT) network.

Lancet. 2015 Oct 17;386(10003):1588-98. doi: 10.1016/S0140-6736(15)00418-3. Review.

PMID:
26530623
12.

Proton detection for signal enhancement in solid-state NMR experiments on mobile species in membrane proteins.

Ward ME, Ritz E, Ahmed MAM, Bamm VV, Harauz G, Brown LS, Ladizhansky V.

J Biomol NMR. 2015 Dec;63(4):375-388. doi: 10.1007/s10858-015-9997-5. Epub 2015 Oct 22.

PMID:
26494649
13.

Detrimental role of hyperuricemia on the cardio-reno-vascular system.

Stack A, Manolis AJ, Ritz E.

Curr Med Res Opin. 2015;31 Suppl 2:21-6. doi: 10.1185/03007995.2015.1087984. Review.

PMID:
26414733
14.

Administration of Cyclosporine A in Pregnant Rats - the Effect on Blood Pressure and on the Glomerular Number in Their Offspring.

Slabiak-Blaz N, Adamczak M, Gut N, Grajoszek A, Nyengaard JR, Ritz E, Wiecek A.

Kidney Blood Press Res. 2015;40(4):413-23. doi: 10.1159/000368515. Epub 2015 Jul 27.

15.

Association of relative telomere length with progression of chronic kidney disease in two cohorts: effect modification by smoking and diabetes.

Raschenberger J, Kollerits B, Ritchie J, Lane B, Kalra PA, Ritz E, Kronenberg F.

Sci Rep. 2015 Jul 7;5:11887. doi: 10.1038/srep11887.

16.

Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients.

Silbernagel G, Fauler G, Genser B, Drechsler C, Krane V, Scharnagl H, Grammer TB, Baumgartner I, Ritz E, Wanner C, März W.

J Am Coll Cardiol. 2015 Jun 2;65(21):2291-8. doi: 10.1016/j.jacc.2015.03.551.

17.

In situ structural studies of Anabaena sensory rhodopsin in the E. coli membrane.

Ward ME, Wang S, Munro R, Ritz E, Hung I, Gor'kov PL, Jiang Y, Liang H, Brown LS, Ladizhansky V.

Biophys J. 2015 Apr 7;108(7):1683-1696. doi: 10.1016/j.bpj.2015.02.018.

18.

Uric Acid and Cardiovascular Events: A Mendelian Randomization Study.

Kleber ME, Delgado G, Grammer TB, Silbernagel G, Huang J, Krämer BK, Ritz E, März W.

J Am Soc Nephrol. 2015 Nov;26(11):2831-8. doi: 10.1681/ASN.2014070660. Epub 2015 Mar 18.

19.

Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk.

Tomaschitz A, Pilz S, Rus-Machan J, Meinitzer A, Brandenburg VM, Scharnagl H, Kapl M, Grammer T, Ritz E, Horina JH, Kleber ME, Pieske B, Kraigher-Krainer E, Hartaigh BÓ, Toplak H, van Ballegooijen AJ, Amrein K, Fahrleitner-Pammer A, März W.

Int J Cardiol. 2015 Apr 1;184:710-6. doi: 10.1016/j.ijcard.2015.03.062. Epub 2015 Mar 4.

PMID:
25777071
20.

Homoarginine in patients with primary hyperparathyroidism.

Tomaschitz A, Verheyen N, Gaksch M, Meinitzer A, Pieske B, Kraigher-Krainer E, Colantonio C, März W, Schmidt A, Belyavskiy E, Rus-Machan J, van Ballegooijen AJ, Stiegler C, Amrein K, Ritz E, Fahrleitner-Pammer A, Pilz S.

Am J Med Sci. 2015 Apr;349(4):306-11. doi: 10.1097/MAJ.0000000000000419.

PMID:
25647833
21.

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies.

Drechsler C, Delgado G, Wanner C, Blouin K, Pilz S, Tomaschitz A, Kleber ME, Dressel A, Willmes C, Krane V, Krämer BK, März W, Ritz E, van Gilst WH, van der Harst P, de Boer RA.

J Am Soc Nephrol. 2015 Sep;26(9):2213-21. doi: 10.1681/ASN.2014010093. Epub 2015 Jan 7.

22.

Longitudinal assessments of erythropoietin-stimulating agent responsiveness and the association with specific clinical outcomes in dialysis patients.

Schneider A, Gutjahr-Lengsfeld L, Ritz E, Scharnagl H, Gelbrich G, Pilz S, Macdougall IC, Wanner C, Drechsler C.

Nephron Clin Pract. 2014;128(1-2):147-52. doi: 10.1159/000367975. Epub 2014 Nov 6.

PMID:
25377947
23.

Impact of aldosterone on osteoinductive signaling and vascular calcification.

Lang F, Ritz E, Alesutan I, Voelkl J.

Nephron Physiol. 2014;128(1-2):40-5. doi: 10.1159/000368268. Epub 2014 Nov 6. Review.

24.

Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.

Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Arita K, Kato A, Shimizu M.

J Am Soc Nephrol. 2015 Jul;26(7):1732-46. doi: 10.1681/ASN.2014010042. Epub 2014 Oct 27.

25.

Phosphate: are we squandering a scarce commodity?

Ferro CJ, Ritz E, Townend JN.

Nephrol Dial Transplant. 2015 Feb;30(2):163-8. doi: 10.1093/ndt/gfu295. Epub 2014 Sep 17.

PMID:
25230707
26.

Glycated hemoglobin predicts overall and cardiovascular mortality in non-diabetic hemodialysis patients.

Ok ES, Asci G, Toz H, Ritz E, Kircelli F, Sever MS, Ozkahya M, Sipahi S, Dheir H, Bozkurt D, Omer Z, Sahin OZ, Ertilav M, Ok E.

Clin Nephrol. 2014 Sep;82(3):173-80.

PMID:
25079862
27.

Diabetic kidney disesase.

Hasslacher C, Wolf G, Kempe P, Ritz E; German Diabetes Association.

Exp Clin Endocrinol Diabetes. 2014 Jul;122(7):391-4. doi: 10.1055/s-0034-1366327. Epub 2014 Jul 11. No abstract available.

PMID:
25014090
28.

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

Silbernagel G, Genser B, Drechsler C, Scharnagl H, Grammer TB, Stojakovic T, Krane V, Ritz E, Wanner C, März W.

J Am Soc Nephrol. 2015 Feb;26(2):484-92. doi: 10.1681/ASN.2013080816. Epub 2014 Jul 10.

29.

Development of the circadian clockwork in the kidney.

Mészáros K, Pruess L, Szabó AJ, Gondan M, Ritz E, Schaefer F.

Kidney Int. 2014 Nov;86(5):915-22. doi: 10.1038/ki.2014.199. Epub 2014 Jun 4.

30.

Introduction to 'Integration of the response to dietary potassium load: a paleolithic perspective'.

Ritz E.

Nephrol Dial Transplant. 2014 May;29(5):981. doi: 10.1093/ndt/gfu095. No abstract available.

PMID:
24789503
31.

Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.

Tomaschitz A, Piecha G, Ritz E, Meinitzer A, Haas J, Pieske B, Wiecek A, Rus-Machan J, Toplak H, März W, Verheyen N, Gaksch M, Amrein K, Kraigher-Krainer E, Fahrleitner-Pammer A, Pilz S.

Clin Exp Hypertens. 2015;37(2):108-15. doi: 10.3109/10641963.2014.913604. Epub 2014 Apr 30.

PMID:
24785704
33.

Aldosterone to active Renin ratio as screening test for primary aldosteronism: reproducibility and influence of orthostasis and salt loading.

Pilz S, Kienreich K, Gaksch M, Grübler M, Verheyen N, Bersuch LA, Schmid J, Drechsler C, Ritz E, Moosbrugger A, Stepan V, Pieber TR, Meinitzer A, März W, Tomaschitz A.

Horm Metab Res. 2014 Jun;46(6):427-32. doi: 10.1055/s-0034-1367033. Epub 2014 Feb 13.

PMID:
24526370
34.

Homoarginine, kidney function and cardiovascular mortality risk.

Tomaschitz A, Meinitzer A, Pilz S, Rus-Machan J, Genser B, Drechsler C, Grammer T, Krane V, Ritz E, Kleber ME, Pieske B, Kraigher-Krainer E, Fahrleitner-Pammer A, Wanner C, Boehm BO, März W.

Nephrol Dial Transplant. 2014 Mar;29(3):663-71. doi: 10.1093/ndt/gft512. Epub 2014 Jan 6.

PMID:
24398889
35.

Erratum: Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease.

Ritz E, Pitt B.

Clin Kidney J. 2013 Dec;6(6):674. doi: 10.1093/ckj/sft143. No abstract available.

36.

Aldosterone and the kidney: a rapidly moving frontier (an update).

Ritz E, Tomaschitz A.

Nephrol Dial Transplant. 2014 Nov;29(11):2012-9. doi: 10.1093/ndt/gft035. Epub 2013 Nov 4. Review.

PMID:
24194611
37.

Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.

Tomaschitz A, Ritz E, Pieske B, Rus-Machan J, Kienreich K, Verheyen N, Gaksch M, Grübler M, Fahrleitner-Pammer A, Mrak P, Toplak H, Kraigher-Krainer E, März W, Pilz S.

Metabolism. 2014 Jan;63(1):20-31. doi: 10.1016/j.metabol.2013.08.016. Epub 2013 Oct 2. Review.

PMID:
24095631
38.

Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease.

Ritz E, Pitt B.

Clin Kidney J. 2013 Oct;6(5):464-8. doi: 10.1093/ckj/sft084. Epub 2013 Sep 1. Erratum in: Clin Kidney J. 2013 Dec;6(6):674.

39.

Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function.

Gut N, Piecha G, Aldebssi F, Schaefer S, Bekeredjian R, Schirmacher P, Ritz E, Gross-Weissmann ML.

Am J Nephrol. 2013;38(2):124-35. doi: 10.1159/000353106. Epub 2013 Jul 30.

PMID:
23920063
40.

Bariatric surgery and the kidney-much benefit, but also potential harm.

Ritz E.

Clin Kidney J. 2013 Aug;6(4):368-72. doi: 10.1093/ckj/sfs161. Epub 2012 Dec 12. Review.

41.

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study.

Coyne DW, Andress DL, Amdahl MJ, Ritz E, de Zeeuw D.

Nephrol Dial Transplant. 2013 Sep;28(9):2260-8. doi: 10.1093/ndt/gft227. Epub 2013 Jun 19.

42.

The calcimimetic R-568 prevents podocyte loss in uninephrectomized ApoE-/- mice.

Gut N, Piecha G, Pradel A, Geldyyev A, Potemkina A, Ritz E, Regele H, Schmitt CP, Gross-Weissmann ML.

Am J Physiol Renal Physiol. 2013 Aug 1;305(3):F277-85. doi: 10.1152/ajprenal.00514.2012. Epub 2013 May 22.

43.

Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study.

Drechsler C, Kollerits B, Meinitzer A, März W, Ritz E, König P, Neyer U, Pilz S, Wanner C, Kronenberg F; MMKD Study Group.

PLoS One. 2013 May 15;8(5):e63560. doi: 10.1371/journal.pone.0063560. Print 2013.

44.

Uric acid and chronic kidney disease: which is chasing which?

Johnson RJ, Nakagawa T, Jalal D, Sánchez-Lozada LG, Kang DH, Ritz E.

Nephrol Dial Transplant. 2013 Sep;28(9):2221-8. doi: 10.1093/ndt/gft029. Epub 2013 Mar 29. Review.

45.

Vascular calcification--is aldosterone a culprit?

Lang F, Ritz E, Voelkl J, Alesutan I.

Nephrol Dial Transplant. 2013 May;28(5):1080-4. doi: 10.1093/ndt/gft041. Epub 2013 Mar 8. Review.

PMID:
23476041
46.

Cinacalcet hydrochloride for the treatment of hyperparathyroidism.

Verheyen N, Pilz S, Eller K, Kienreich K, Fahrleitner-Pammer A, Pieske B, Ritz E, Tomaschitz A.

Expert Opin Pharmacother. 2013 Apr;14(6):793-806. doi: 10.1517/14656566.2013.777041. Epub 2013 Mar 4. Review.

PMID:
23452174
47.

Vasopressin: a novel target for the prevention and retardation of kidney disease?

Bankir L, Bouby N, Ritz E.

Nat Rev Nephrol. 2013 Apr;9(4):223-39. doi: 10.1038/nrneph.2013.22. Epub 2013 Feb 26. Review.

PMID:
23438973
48.

Circulating aldosterone and mortality in female nursing home residents.

Tomaschitz A, Pilz S, Pieske B, Ritz E, März W, Meinitzer A, Dobnig H, Amrein K, Kienreich K, Verheyen N, Kraigher-Krainer E, Drechsler C, Colantonio C, Wagner D, Fahrleitner-Pammer A.

Exp Gerontol. 2013 Mar;48(3):313-8. doi: 10.1016/j.exger.2013.01.004. Epub 2013 Jan 16.

PMID:
23333370
49.

Clinical manifestations and natural history of diabetic kidney disease.

Ritz E.

Med Clin North Am. 2013 Jan;97(1):19-29. doi: 10.1016/j.mcna.2012.10.008. Review.

PMID:
23290727
50.

Prevalence of microalbuminuria in type 2 diabetes: lessons learned from the ROADMAP study.

Ritz E, Menne J, Haller H.

Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv28-30. doi: 10.1093/ndt/gfs424. No abstract available.

PMID:
23258807

Supplemental Content

Support Center